Intravenous lidocaine for neuropathic pain: Diagnostic utility and therapeutic efficacy

被引:19
|
作者
Carroll I. [1 ]
机构
[1] Stanford University School of Medicine, Palo Alto, CA 94034
关键词
Lidocaine; Neuropathic Pain; Complex Regional Pain Syndrome; Mexiletine; Mechanical Allodynia;
D O I
10.1007/s11916-007-0017-7
中图分类号
学科分类号
摘要
Lidocaine is a use-dependent sodium channel blocker that produces analgesia when administered intravenously to patients with neuropathic pain. This article reviews the role and limitations of intravenous lidocaine infusions for neuropathic pain. Lidocaine infusions rarely provide relief that persists significantly beyond the duration of the infusion. Diagnostically, systemic lidocaine may help establish the presence of neuropathic pain and the responsivity to oral sodium channel blockade. However, the data supporting diagnostic infusions remain sparse. Therapeutically, infusions should generally be restricted to patients with neuropathic pain who are unable to take oral medication. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:20 / 24
页数:4
相关论文
共 50 条
  • [31] Topical lidocaine for neuropathic pain in adults
    Derry, Sheena
    Wiffen, Philip J.
    Moore, R. Andrew
    Quinlan, Jane
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [32] Efficacy of intraperitoneal and intravenous lidocaine on pain relief after laparoscopic cholecystectomy
    Yang, So Young
    Kang, Hyun
    Choi, Geun Joo
    Shin, Hwa Yong
    Baek, Chong Wha
    Jung, Yong Hun
    Choi, Yoo Shin
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (02) : 307 - 319
  • [33] A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life
    Buchanan, D. Deans
    MacIvor, Frances J.
    SUPPORTIVE CARE IN CANCER, 2010, 18 (07) : 899 - 901
  • [34] Efficacy of Intravenous Immunoglobulin (IVIG) Treatment in Patients with Neuropathic Corneal Pain
    Bayraktutar, Betul
    Farhad, Khosro
    Soto, Oscar
    Hamrah, Pedram
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [35] A RANDOMIZED DOUBLE-BLIND CROSSOVER TRIAL OF INTRAVENOUS LIDOCAINE IN THE TREATMENT OF NEUROPATHIC CANCER PAIN
    BRUERA, E
    RIPAMONTI, C
    BRENNEIS, C
    MACMILLAN, K
    HANSON, J
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (03) : 138 - 140
  • [36] A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life
    D. Deans Buchanan
    Frances J. MacIvor
    Supportive Care in Cancer, 2010, 18 : 899 - 901
  • [37] TOPICAL LIDOCAINE RELIEVES PERIPHERAL NEUROPATHIC PAIN
    GALER, BS
    NEUROLOGY, 1995, 45 (04) : A366 - A366
  • [38] Lidocaine 5% Patch in Localized Neuropathic Pain
    Nair, Abhijit S.
    Mantha, Srinivasa Shyam Prasad
    Azharuddin, Mohammad
    Rayani, Basanth Kumar
    INDIAN JOURNAL OF PALLIATIVE CARE, 2019, 25 (04) : 594 - +
  • [39] New analgesics for neuropathic pain: The lidocaine patch
    Argoff, CE
    CLINICAL JOURNAL OF PAIN, 2000, 16 (02): : S62 - S66
  • [40] SUBCUTANEOUS LIDOCAINE FOR TREATMENT OF NEUROPATHIC CANCER PAIN
    BROSE, WG
    COUSINS, MJ
    PAIN, 1991, 45 (02) : 145 - 148